Effect of Lumacaftor-ivacaftor on Glucose Handling and Tolerance in Cystic Fibrosis Phe508del
Status:
Withdrawn
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to find out if the combined therapy
lumacaftor-ivacaftor effects how people with cystic fibrosis respond to an oral glucose
tolerance test, a test for diabetes.